Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP680932.RAwf2PbjHmw-PIwTkaqEU2r49yOT-IbTX7M7VymLKtR2k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP680932.RAwf2PbjHmw-PIwTkaqEU2r49yOT-IbTX7M7VymLKtR2k130_assertion type Assertion NP680932.RAwf2PbjHmw-PIwTkaqEU2r49yOT-IbTX7M7VymLKtR2k130_head.
- NP680932.RAwf2PbjHmw-PIwTkaqEU2r49yOT-IbTX7M7VymLKtR2k130_assertion wasGeneratedBy ECO_0000203 NP680932.RAwf2PbjHmw-PIwTkaqEU2r49yOT-IbTX7M7VymLKtR2k130_provenance.
- NP680932.RAwf2PbjHmw-PIwTkaqEU2r49yOT-IbTX7M7VymLKtR2k130_assertion wasDerivedFrom befree-20140225 NP680932.RAwf2PbjHmw-PIwTkaqEU2r49yOT-IbTX7M7VymLKtR2k130_provenance.
- NP680932.RAwf2PbjHmw-PIwTkaqEU2r49yOT-IbTX7M7VymLKtR2k130_assertion SIO_000772 17875526 NP680932.RAwf2PbjHmw-PIwTkaqEU2r49yOT-IbTX7M7VymLKtR2k130_provenance.
- NP680932.RAwf2PbjHmw-PIwTkaqEU2r49yOT-IbTX7M7VymLKtR2k130_assertion evidence source_evidence_literature NP680932.RAwf2PbjHmw-PIwTkaqEU2r49yOT-IbTX7M7VymLKtR2k130_provenance.
- NP680932.RAwf2PbjHmw-PIwTkaqEU2r49yOT-IbTX7M7VymLKtR2k130_assertion description "[We investigated the prevalence of the JAK2 V617F gain-of-function mutation in patients with Philadelphia chromosome-negative chronic myeloproliferative disorders (Ph- MPD) and explored the links between JAK2 mutational status and the clinicopathologic picture of essential thrombocythemia (ET), chronic idiopathic myelofibrosis (CIMF), and polycythemia vera (PV).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680932.RAwf2PbjHmw-PIwTkaqEU2r49yOT-IbTX7M7VymLKtR2k130_provenance.